Study S001050

Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT02496611
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 100
Start: 2015-12
Primary completion: 2020-08-14
Lead sponsor: University of Minnesota
Conditions: Severe Obesity
Interventions: DRUG:Weight loss with pharmacotherapy; DRUG:Weight loss without pharmacotherapy
Results posted: TRUE

Registered primary outcomes

Body Mass Index [52 weeks]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0012128	Meal Replacement Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents with Severe Obesity. Rode JB, Childhood obesity (Print)	2026	Other trial	PMID 42281167 DOI	cites ClinicalTrials.gov:NCT02496611; registry reference DERIVED:42281167
R0021733	Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial. Fox CK, Obesity (Silver Spring, Md.)	2022	Randomized trial	PMID 35403350 DOI	cites ClinicalTrials.gov:NCT02496611; registry reference DERIVED:35403350